TET2 has been found mutated in patients with myeloproliferative neoplasms (MPN), MDS, AML and chronic myelomonocytic leukemia (CMML), and is the most commonly mutated gene in MDS [68-72]. This evidence concerns the gene TET2 and acute myeloid leukemia.